Through these three programs, we’re bringing together the national early psychosis community like never before – to work collaboratively and effectively to improve outcomes for young people experiencing early psychosis.
As a clinical trials network, the AEPCC CTTN will be an enabling platform to facilitate early psychosis research across Australia, the first of its kind in youth mental health and early psychosis. We have added an additional element – translation – to ensure research findings are translated into clinical practice.
While the AEPCC CTTN is the only mental health clinical trials network focused exclusively on young people, two clinical trials networks in the mental health sector are also being established: MAGNET and Growing Minds Australia.
